Osaic Holdings
KPTI icon

Osaic Holdings’s Karyopharm Therapeutics KPTI Stock Holding History

Osaic Holdings’s Portfolio KPTI Stock Details KPTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.93K Hold
402
– – ﹤0.01% 7040
2026
Q1 		$2.24K Buy
402
+120
+43% +$915 ﹤0.01% 7009
2025
Q4 		$2.08K Sell
282
-64
-18% -$391 ﹤0.01% 7083
2025
Q3 		$2.41K Hold
346
– – ﹤0.01% 7083
2025
Q2 		$1.49K Hold
346
– – ﹤0.01% 7039
2025
Q1 		$1.29K Sell
346
-13
-4% -$111 ﹤0.01% 6742
2024
Q4 		$3.66K Buy
359
+66
+23% +$798 ﹤0.01% 6353
2024
Q3 		$3.64K Sell
293
-188
-39% -$2.34K ﹤0.01% 6359
2024
Q2 		$6.27K Sell
481
-92
-16% -$1.52K ﹤0.01% 6060
2024
Q1 		$13K Buy
573
+143
+33% +$2.51K ﹤0.01% 5611
2023
Q4 		$5.57K Sell
430
-33
-7% -$445 ﹤0.01% 6128
2023
Q3 		$9.3K Sell
463
-9
-2% -$202 ﹤0.01% 5947
2023
Q2 		$12.5K Sell
472
-122
-21% -$5.25K ﹤0.01% 5850
2023
Q1 		$34.6K Hold
594
– – ﹤0.01% 5210
2022
Q4 		$30K Buy
594
+341
+135% +$23.6K ﹤0.01% 5289
2022
Q3 		$21K Buy
253
+10
+4% +$747 ﹤0.01% 5546
2022
Q2 		$16K Hold
243
– – ﹤0.01% 5764
2022
Q1 		$27K Sell
243
-99
-29% -$12.3K ﹤0.01% 5491
2021
Q4 		$33K Sell
342
-1,074
-76% -$107K ﹤0.01% 5445
2021
Q3 		$124K Buy
1,416
+569
+67% +$59.1K ﹤0.01% 4333
2021
Q2 		$131K Sell
847
-36
-4% -$5.22K ﹤0.01% 4243
2021
Q1 		$139K Sell
883
-662
-43% -$139K ﹤0.01% 4082
2020
Q4 		$359K Sell
1,545
-6
-0.4% -$1.39K ﹤0.01% 2947
2020
Q3 		$340K Sell
1,551
-127
-8% -$31.1K ﹤0.01% 2778
2020
Q2 		$477K Buy
1,678
+520
+45% +$154K ﹤0.01% 2386
2020
Q1 		$333K Buy
+1,158
New +$319K ﹤0.01% 2434

Other funds holding KPTI

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Osaic Holdings's KPTI Position: Q2 2026 in Review

Osaic Holdings held its Karyopharm Therapeutics (KPTI) position steady in Q2 2026 at 402 shares worth $3.93K. The position accounts for ﹤0.01% of the portfolio, ranked #7040.

Osaic Holdings first reported a position in KPTI in Q1 2020 and has held it in 26 quarters since. The position peaked at $477K in Q2 2020. 97 funds tracked by Wall St. Rank hold KPTI as of Q2 2026.

  • Osaic Holdings held 402 shares of Karyopharm Therapeutics worth $3.93K as of Q2 2026.
  • Osaic Holdings left its Karyopharm Therapeutics share count unchanged in Q2 2026.
  • Karyopharm Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7040 holding.
  • Osaic Holdings first reported a position in Karyopharm Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Karyopharm Therapeutics position peaked at $477K in Q2 2020.
  • 97 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.